OBL Pharm Overview

  • Founded
  • 1994
Founded
  • Status
  • Private
  • Employees
  • 700
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Financing Rounds
  • 4
  • Investments
  • 1

OBL Pharm General Information

Description

Manufacturer of generic drugs based in Moscow, Russia. The company is engaged in the development, production and marketing of drugs for the treatment of cardiovascular, gastrointestinal, endocrine, phlebological and viral diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • Building 11, 4th floor
  • 14 Kozhevnicheskaya Street
  • Moscow, 115114
  • Russia
+7 8 (000) 000-00-00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OBL Pharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OBL Pharm‘s full profile, request access.

Request a free trial

OBL Pharm Executive Team (2)

Name Title Board Seat Contact Info
Alexey Molotkov Chief Financial Officer
You’re viewing 1 of 2 executive team members. Get the full list »

OBL Pharm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OBL Pharm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OBL Pharm‘s full profile, request access.

Request a free trial

OBL Pharm Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 07-Apr-2014 0000000000 Drug Delivery 000000 0000000000
To view OBL Pharm’s complete investments history, request access »